Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis B

被引:70
作者
Jin, Xi [1 ]
Chen, Yi-peng [1 ]
Yang, Yi-da [2 ]
Li, You-ming [1 ]
Zheng, Lin [2 ]
Xu, Chuan-qing [1 ]
机构
[1] Zhejiang Univ, Dept Gastroenterol, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Dept Infect Dis, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
来源
PLOS ONE | 2012年 / 7卷 / 03期
基金
中国国家自然科学基金;
关键词
FATTY LIVER-DISEASE; NATURAL-HISTORY; EPIDEMIOLOGY; REDUCTION;
D O I
10.1371/journal.pone.0034198
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The coexistence of HBV infection and nonalcoholic fatty liver disease (NAFLD) becomes characteristic of liver disease in China, with unknown bilateral influence. We aimed to investigate the effect of hepatic steatosis, a common hepatocyte change in NAFLD, on antiviral therapy in patients with chronic hepatitis B (CHB). Methods and Findings: We carried out a prospective nested case control study in CHB patients receiving Entecavir for initial antiviral therapy, by recording demographic, anthropometric and clinical data at baseline, 24(wk), 48(wk) and 96(wk). Univariate analysis and multivariate logistic regression were applied to find out independent factors of hepatic steatosis and Entecavir treatment failure. The rates of HBV-DNA clearance, HBeAg seroconversion and ALT normalization were compared between CHB patients with and without steatosis by post hoc analysis. A total of 267 Chinese patients with CHB entered final analysis, with overall percentages of hepatic steatosis and HBeAg positive as 30.5% and 62.4%. Multivariate analysis showed waist circumference, serum TG and uric acid levels were independent factors of hepatic steatosis. The response rates to Entecavir were 54.9%, 63.8%, 74.2% at 24(wk), 48(wk) and 96(wk). Hepatic steatosis was revealed as an independent factor of Entecavir treatment failure by multivariate logistic regression at 24(wk), 48(wk) and 96(wk). In CHB patients with hepatic steatosis, HBV-DNA clearance and HBeAg seroconversion were both lower throughout the follow-up, but only the former reached statistical significance. Besides, ALT normalization was also significantly lower at 24(wk) and 48(wk). Conclusion: Hepatic steatosis is significantly associated with Entecavir treatment failure and metabolic factors are independent factors of hepatic steatosis in CHB patients, which called for a specified antiviral strategy in CHB patients with NAFLD.
引用
收藏
页数:6
相关论文
共 29 条
[1]   Viral and host causes of fatty liver in chronic hepatitis B [J].
Altiparmak, Emin ;
Koklu, Seyfettin ;
Yalinkilic, Mesut ;
Yuksel, Osman ;
Cicek, Bahattin ;
Kayacetin, Ertugrul ;
Sahin, Tulin .
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (20) :3056-3059
[2]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[3]   Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD) [J].
Bellentani, Stefano ;
Marino, Mariano .
ANNALS OF HEPATOLOGY, 2009, 8 :S4-S8
[4]   Hepatitis C and steatosis [J].
Bjornsson, Einar ;
Angulo, Paul .
ARCHIVES OF MEDICAL RESEARCH, 2007, 38 (06) :621-627
[5]   A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B [J].
Chang, TT ;
Gish, RG ;
de Man, R ;
Gadano, A ;
Sollano, J ;
Chao, YC ;
Lok, AS ;
Han, KH ;
Goodman, Z ;
Zhu, J ;
Cross, A ;
DeHertogh, D ;
Wilber, R ;
Colonno, R ;
Apelian, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) :1001-1010
[6]  
Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P13, DOI 10.3760/cma.j.issn.1007-3418.2011.01.007
[7]   Hepatic steatosis has no impact on the outcome of treatment in patients with chronic hepatitis B infection [J].
Cindoruk, Mehmet ;
Karakan, Tarkan ;
Unal, Selahattin .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (05) :513-517
[8]   Global epidemiology of hepatitis B virus [J].
Custer, B ;
Sullivan, SD ;
Hazlet, TK ;
Iloeje, U ;
Veenstra, DL ;
Kowdley, KV .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (10) :S158-S168
[9]   Epidemiology of non-alcoholic fatty liver disease in China [J].
Fan, Jian-Gao ;
Farrell, Geoffrey C. .
JOURNAL OF HEPATOLOGY, 2009, 50 (01) :204-210
[10]   Steatosis in chronic hepatitis C: can weight reduction improve therapeutic efficacy? [J].
Giannini, E ;
Ceppa, P ;
Testa, R .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :432-433